Glioblastoma represents one of the most aggressive and challenging brain tumors facing adults today,and current treatment options often onyl manage to slow its progression. However, groundbreaking research from Washington University School of Medicine and Northwestern University suggests a potential turning point: a novel nano-drug platform deliverable through the nose. Early animal studies have demonstrated a critically important strengthening of the immune response against the tumor and a remarkably improved treatment efficacy.
